These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16775189)

  • 1. Transforming growth factor beta receptor type I and transforming growth factor beta1 polymorphisms are not associated with postmenopausal breast cancer.
    Feigelson HS; Patel AV; Diver WR; Stevens VL; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1236-7. PubMed ID: 16775189
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers.
    Jin Q; Hemminki K; Grzybowska E; Klaes R; Söderberg M; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Pamula J; Pekala W; Försti A
    Int J Cancer; 2004 Oct; 112(1):94-9. PubMed ID: 15305380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
    Chen T; Jackson CR; Link A; Markey MP; Colligan BM; Douglass LE; Pemberton JO; Deddens JA; Graff JR; Carter JH
    Clin Cancer Res; 2006 Jan; 12(2):392-7. PubMed ID: 16428477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
    McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
    BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.
    Le Marchand L; Haiman CA; van den Berg D; Wilkens LR; Kolonel LN; Henderson BE
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):412-5. PubMed ID: 15006917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies.
    Zhang HT
    Lung Cancer; 2005 Sep; 49(3):419-20. PubMed ID: 15955593
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation.
    Hattori H; Matsuzaki A; Suminoe A; Ihara K; Nagatoshi Y; Sakata N; Kawa K; Okamura J; Hara T
    Bone Marrow Transplant; 2002 Nov; 30(10):665-71. PubMed ID: 12420205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas.
    Woszczyk D; Gola J; Jurzak M; Mazurek U; Mykała-Cieśla J; Wilczok T
    Med Sci Monit; 2004 Jan; 10(1):CR33-7. PubMed ID: 14704634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages.
    Shin A; Shu XO; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1567-70. PubMed ID: 15941974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression.
    Goldberg SR; McKinstry RP; Sykes V; Lanning DA
    J Pediatr Surg; 2007 Jun; 42(6):966-71; discussion 971-3. PubMed ID: 17560204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of recognition site between transforming growth factor-beta1 (TGF-beta1) and TGF beta receptor type II: possible implications in breast cancer.
    Ivanović V; Demajo M; Todorović-Raković N; Nikolić-Vukosavljević D; Nesković-Konstantinović Z; Krtolica K; Veljković V; Prljić J; Dimitrijević B
    Med Hypotheses; 2004; 62(5):727-32. PubMed ID: 15082097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of childhood acute lymphoblastic leukaemia and polymorphisms in the TGF-beta and receptor genes.
    Dai L; Gast A; Horska A; Schrappe M; Bartram CR; Hemminki K; Kumar R; Bermejo JL
    Pediatr Blood Cancer; 2009 Jul; 52(7):819-23. PubMed ID: 19229971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible association between genetic polymorphisms in transforming growth factor beta receptors, serum transforming growth factor beta1 concentration and abdominal aortic aneurysm.
    Golledge J; Clancy P; Jones GT; Cooper M; Palmer LJ; van Rij AM; Norman PE
    Br J Surg; 2009 Jun; 96(6):628-32. PubMed ID: 19434696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma.
    Anbazhagan R; Bornman DM; Johnston JC; Westra WH; Gabrielson E
    Cancer Res; 1999 Jul; 59(14):3363-4. PubMed ID: 10416594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 enhances transforming growth factor-beta 1 and TGF-beta receptors synthesis: an in vivo and in vitro study.
    Ramirez-Yañez GO; Hamlet S; Jonarta A; Seymour GJ; Symons AL
    Prostaglandins Leukot Essent Fatty Acids; 2006 Mar; 74(3):183-92. PubMed ID: 16504491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TbetaR-I(6A) is a candidate tumor susceptibility allele.
    Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
    Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.
    Pasche B; Kaklamani V; Hou N; Young T; Rademaker A; Peterlongo P; Ellis N; Offit K; Caldes T; Reiss M; Zheng T
    J Clin Oncol; 2004 Feb; 22(4):756-8. PubMed ID: 14966109
    [No Abstract]   [Full Text] [Related]  

  • 20. PCR-RFLPs, linkage and RH mapping of the porcine TGFB1 and TGFBR1 genes.
    Kopecný M; Stratil A; Van Poucke M; Bartenschlager H; Geldermann H; Peelman LJ
    Anim Genet; 2004 Jun; 35(3):253-5. PubMed ID: 15147406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.